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Abstract. Calcineurin is a calcium-dependent protein 
phosphatase that functions in T cell activation. We 
present evidence that calcineurin functions more gener- 
ally in calcium-triggered apoptosis in mammalian cells 
deprived of growth factors. Specifically, expression of 
epitope-tagged calcineurin A  induces rapid cell death 
upon calcium signaling in the absence of growth factors. 
We show that this apoptosis does not require new pro- 
tein synthesis and therefore calcineurin must operate 
through existing substrates. Co-expression of the Bcl-2 
protooncogene efficiently blocks calcineurin-induced 
cell death. Significantly, we demonstrate that a calcium- 
independent calcineurin mutant induces apoptosis in 
the absence of calcium, and that this apoptotic response 
is a direct consequence of calcineurin's phosphatase ac- 
tivity. These data suggest that calcineurin plays an im- 
portant role in mediating the upstream events in cal- 
cium-activated cell death. 
OPTOSlS is an active process by which a multicellular 
organism eliminates defective, destructive, or re- 
dundant cells.  This  process  is  invoked  in  many 
steps of development, proliferation, immunological toler- 
ance, and disease (Ellis et al.,  1991; Martin et al.,  1994; 
Reed,  1994).  Genetic  studies  have  uncovered  a  set  of 
genes  regulating  the  onset  of  apoptosis  during  pro- 
grammed cell death. The ced-3  and ced-4 genes of Cae- 
norhabditis  elegans are necessary for the commitment to 
programmed cell death.  Ced-9, which encodes a  protein 
with structural  and  functional homology to  mammalian 
Bcl-2,  counteracts  ced-3  and  ced-4  (Yuan  and  Horvitz, 
1990; Hengartner and Horvitz, 1994). The over-expression 
of Bcl-2 is thought to contribute to B cell lymphomas by 
promoting cell survival despite aberrant proliferation sig- 
nals (Tsujimoto et al., 1984; Bakhshi et al., 1985; Cleary 
and Sklar, 1985). In experimental systems, over-expression 
of Bcl-2 has been shown to prevent apoptosis induced by 
elevated calcium levels, or by c-myc and p53 over-expres- 
sion  (Hockenbery  et  al.,  1990; Sentman  et  al.,  1991; 
Strasser et al., 1991; Reed, 1994). 
Many of the stimuli leading to cell death support  the 
view that apoptosis is a mechanism to remove cells which 
experience inappropriate or contradictory signals, such as 
in  transformation or  viral  infection  (Evan  et  al.,  1992; 
Debbas  and White, 1993; Harrington et al.,  1994).  Thus 
c-myc over-expression, which is generally associated with 
cell proliferation, activates cell death in the absence of co- 
incident growth factor stimulation (Evan et al., 1992). The 
different fates of immature and mature T cells responding 
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to T cell receptor (TCR) 1 activation underscore the com- 
plex interactions between apoptotic and growth pathways. 
Stimulation of the TCR on immature T cells drives them 
into apoptosis rather than the proliferative state assumed 
by mature T cells (Smith et al.,  1989; Ucker et al., 1989). 
Moreover, even mature T  ceils undergo apoptosis when 
confronted with continuous TCR stimulation, suggesting a 
wide use of cell death at many stages of the immune re- 
sponse (Singer and Abbas, 1994). 
Calcium signaling is upstream of certain pathways that 
lead  to  apoptosis,  including  neuronal  cell  death  via 
glutamate-induced excitotoxicity and cell death in T cells 
(Choi,  1992; Reed,  1994).  Additionally,  calcium  iono- 
phores cause apoptosis in a number of experimental sys- 
tems, implying that elevated  intracellular calcium influ- 
ences the decision to enter apoptosis. The ability of Bcl-2 
to block most cases of calcium-induced apoptosis suggests 
that calcium stimulates a common pathway affecting the 
commitment to cell death (Barr and Tomei, 1994; Reed, 
1994). While the mechanism of Bcl-2 action is uncertain, it 
has been implicated in antioxidant pathways to prevent 
the generation of reactive oxygen species associated with 
cell death (Hockenbery et al., 1993). More recently, Bcl-2 
has been implicated in regulation of calcium efflux from 
the endoplasmic reticulum, and may thereby influence cal- 
cium-dependent apoptotic pathways (Lam et al., 1994). 
Despite extensive studies linking calcium to cell death, 
the immediate targets of this calcium flux remain largely 
unknown.  One  potential  mediator  of calcium  signaling 
during apoptosis is the family of calcium-activated phos- 
phatases known as calcineurin (protein phosphatase 2B; 
1. Abbreviations used in this paper: CnA, calcineurin A; CsA, cyclosporin 
A; HA, hemagglutinin; TCR, T cell receptor; TdT, terminal deoxynucleo- 
tidyl transferase; TUNEL, TdT-mediated UTP nick end-labeling. 
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that  expression of this  calcium-activated phosphatase  in 
mammalian cells greatly potentiates the cell death due to 
calcium signaling.  Moreover, a  constitutively active, cal- 
cium-independent calcineurin mutant completely bypasses 
the requirement for calcium signaling in this cell death. 
Materials and Methods 
Cell Culture 
BHK-21 cells were obtained from the American Type Culture Collection 
(Rockville, MD)  and maintained in a  5%  CO2  atmosphere at 37°C  in 
DME (GIBCO BRL, Gaithersburg, MD) supplemented with 10%  fetal 
bovine serum (Hyclone Labs., Logan, UT), 2  mM glutamine (GIBCO 
BRL), and 100 i~g/ml of penicillin-streptomycin (GIBCO BRL). 
Construction of Calcineurin A and B 
Expression Vectors 
The eDNA encoding human calcineurin A  (CnA [3-isotype; Guerini and 
Klee, 1989), and human calcineurin B (Guerini et al., 1989) were obtained 
from  a  T  cell  hgtl0  library  using  oligonucleotides as  a  hybridization 
probes (Maniatis et aL, 1982).  CnA was cloned into the mammalian ex- 
pression vector pCMV1 (Pharmacia, Piscataway, NJ) 200-bp '5-untrans- 
lated sequence from human lamin A  and an NH2-terminal influenza he- 
magglutinin (HA)-tag using oligonucleotides and PCR techniques (Heald 
et al., 1993). CnA lacking the autoinhibitory domain and the CaM binding 
domain (ACnA) was constructed using PCR to introduce a stop codon af- 
ter N4o7.  CnB was cloned into pCMV1 after the lamin untranslated re- 
gion but without an epitope tag. The Bcl-2 expression vector, pCMV-bcl.2, 
was a generous gift of Stanley Korsmeyer (Washington University School 
of Medicine, St. Louis, MO). 
DNA Transfections 
DNA transfections were performed as described previously (Heald et al., 
1993). 16,000 cells were plated onto each coverslip in 400 ~l of medium. 
On day 1, a total of 2 pLg of cesium chloride-purified plasmid DNA was 
added to 30 ~l of 0.2 M  CaC12 and precipitated by adding 30 izL of 2× 
Hepes-buffered saline over 15 s with stirring. After 20 min, 350 p.1 of com- 
plete medium was added to the DNA precipitate, and the mixture applied 
to the cells. Each coverslip was allowed to incubate in the tissue culture in- 
cubator for 4 h. The coverslips were then washed twice with complete me- 
dium and returned to the incubator for an additional 12 h. 
Immunofluorescence 
Cells on coverslips were fixed in 3 % formaldehyde (Baker Co., Inc., San- 
ford, ME) in PBS for 10 min and then washed three times with 0.1% NP- 
40 (Sigma Chem. Co., St. Louis, MO) in PBS (PBS-NP-40). Primary anti- 
bodies were incubated on the coverslips for 30 min, followed by four rapid 
rinses with PBS-NP-40. The 9E10 anti-c-myc epitope monoclonal anti- 
body was obtained from the American Type Culture Collection, and the 
anti-HA epitope monoclonal antibody (12CA5) purchased from BAbCO 
(Berkeley, CA). The polyclonal antibody against the HA epitope was pur- 
chased from MBL International Corporation  (MCI, Watertown, MA). 
CyLconjugated secondary antibodies (Jackson ImmunoResearch Labs., 
Inc., West Grove, PA) were incubated on the coverslips for an additional 
30 rain. DNA was labeled using Hoechst dye 33258 (Sigma Chem. Co.) at 
10 p~g/ml PBS-NP40 for 1 min. Coverslips were mounted on glass slides in 
90% glycerol, 20 mM Tris-HCl (pH 9.35). 
Western Blotting 
Coverslips were washed twice with ice-cold PBS, and the cells were ex- 
tracted with 200 pA of pre-heated (70°C) 2× SDS sample buffer containing 
10% 2-mercaptoethanol. The extract was transferred to a microcentrifuge 
tube, boiled for 5 rain, and centrifuged at 10,000 g for 10 min. 25 ~l of each 
sample was analyzed by 8% SDS gel electrophoresis and electrophoreti- 
cally transferred to  Immobilon membranes (Millipore Corp., Bedford, 
MA). The membranes were blocked overnight in 0.1%  Tween-20 PBS 
(0.1% Tween-PBS) containing 5% nonfat dry milk and incubated in pri- 
mary antibody for 1 h at room temperature. After four 5-min washes with 
blocking solution, membranes were incubated with goat anti-rabbit anti- 
body conjugated to horseradish peroxidase (Jackson ImmunoResearch 
Labs., Inc.) for 1 h. Membranes were then washed and developed using 
chemiluminescence reagents (ECL; Amersham Corp., Arlington Heights, 
IL) and exposed to XAR-5 film (Kodak). 
DNA Nick End Labeling (TUNEL Method) 
To  detect DNA fragmentation in situ, we modified the previously de- 
scribed TUNEL method (Tilly  and Hsueh, 1993; Surh and Sprent, 1994) 
as follows. Cells were fixed and washed with PBS-NP-40 and TdT buffer 
(0.5 M cacodylate, 25 mM Tris, pH 6.8, 150 mM NaC1, 5 mM CoC12, 0.5 
mM DTT, and 0.05% BSA), and then incubated for 1 h at 37°C with 2-5 
p.M digoxigenin-conjugated dUTP (Boehringer Mannheim Biochemicals, 
Indianapolis, IN) and 5-10 U TdT (terminal transferase; Promega Biotec, 
Madison,WI) in 50 p.l TdT buffer per coverslip. After washing and block- 
ing, cells were incubated with 0.5  ~,g/ml anti-digoxigenin mouse mono- 
clonal antibody (Boehringer Mannheim Biochemicals), washed, and then 
incubated with an FITC-labeled  anti-mouse antibody (Jackson Immu- 
noResearch Labs., Inc.). 
Immunoprecipitations  and Calcineurin 
Phosphatase Assays 
Transfected cells on coverslips were lysed in 200 i~l of buffer A  (50 mM 
Tris-HC1,  pH 7.5, i  mM EDTA, 0.5% Tween-20, 0.5 mg/ml BSA, 1 mM 
DTT, I mM PMSF, 1 p~g/ml  leupeptin and 1 I~g/ml pepstatin), transferred 
to a microfuge tube, and centrifuged at 10,000 g for 5 min at 4°C. The su- 
pernatant was transferred to a new tube and 5 ~1 of the anti-HA epitope 
(12CA5) monoclonal antibody (BAbCO) and 30 p.1 of protein G-Sepha- 
rose (1:1 slurry; Sigma Chem. Co.) were added. Tubes were rotated at 4°C 
for I h. The Sepharose beads were pelleted by centrifugation and washed 
three times in buffer A. Phosphatase activity associated with the immuno- 
precipitates was determined by following [32p]phosphate released from 
the RII peptide essentially as described (Milan et al., 1994). 
Calcineurin activity from whole cell lysates of transfected and mock- 
transfected cells was determined by a modification of the assay developed 
by Fruman and colleagues (Fruman et al., 1992). Cells were scraped from 
coverslips in 200 ~l of PBS, pelleted at 10,000 g for 15 s, resuspended in 50 
I~l hypotonic lysis buffer (50 mM Tris-HC1,  pH 7.4, 1 mM EDTA, 1 mM 
CaCl2, 1 mM PMSF, 1 p~g/ml pepstatin, 1 p.g/ml leupeptin, 1 mM DTr), 
and subjected to three rounds of freeze-thaw. After removing cell debris 
by centrifugation, 50 ixl of phosphatase buffer (100 mM Tris-HCl, pH 7.4, 
1 mM MnC12, 0.1 mM CaC12, 0.5 mg/ml BSA, 100 nM calmodulin, and 0.5 
mM DTT) was added to the supernatant. 500 nM okadaic acid was added 
to the reactions to suppress endogenous protein phosphatases PP1 and 
PP2A (Fruman et al., 1992). The SEp-labeled Rll peptide was incubated in 
the extracts for 30 min at 30°C. To determine the specific contribution of 
ACnA to the phosphatase activity of the lysates, 1 mM EGTA was added 
prior to the start of the reaction to suppress endogenous calcineurin activ- 
ity. The effects of immunophilin--drug complexes on calcineurin activity of 
these lysates was determined using 0.5 ~M cyclosporin A (CsA) and 1 p.M 
human cyclophilin B (Price et al., 1991). Reactions were stopped by add- 
ing 500 p,l of stop buffer (10% TCA, 0.1 M sodium phosphate) and 10 p.l 
of 10 mg/ml BSA to each tube. These tubes were incubated on ice for 10 
min, centrifuged at 10,000 g for 10 min, and the released [sZP]phosphate 
was determined as described (Milan et al., 1994). 
Results 
Calcineurin Induces Calcium-dependent Cell Death 
in the Absence of Growth Factors 
To assess the effect of exogenous calcineurin expression 
on mammalian cells, we transfected BHK cells with vec- 
tors expressing an HA-epitope-tagged catalytic subunit of 
calcineurin (~-isotype of CnA) and its regulatory subunit, 
CnB (Guerini and Klee, 1989; Guerini et al.,  1989; Milan 
et  al.,  1994;  Fig.  1 A).  Co-transfection  of the  two  cal- 
cineurin subunits appears to be essential for efficient cal- 
cineurin expression in mammalian cellsl as immunoblot- 
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cells.  (A)  Domain  structure  of  human  calcineurin  A  (CnA), 
ACnA,  and calcineurin  B  (CnB).  The eDNA encoding  human 
CnA (13-isotype)  was modified by an insertion  of an HA-epitope 
coding sequence  at its NH2 terminus.  HA, Catalytic, CnB, CaM, 
and AI represent the  hemagglutinin-epitope,  catalytic  domain, 
calcineurin  B-binding  domain, calmodulin-binding  domain,  and 
auto-inhibitory  domain, respectively. The human CnB cDNA en- 
codes  four  Ca2+-binding  domains  (black  boxes)  and  was  ex- 
pressed in its wild type form. (B) Total cell lysates prepared from 
BHK cells transiently  transfected with control vector alone (lane 
1), CnA alone (1 Ixg CnA, 1 I~g control vector, lane 2), both CnA 
and CnB (1 ~g each, lane 3) were fractionated by polyacrylamide 
gel electrophoresis,  transferred to Immobilon membranes, and 
probed with the anti-HA-epitope antibody to detect CnA. The 
molecular weight markers indicate  the mobility of bovine serum 
albumin  (68 kD) and ovalbumin (45 kD). (C) Immunofluores- 
cence  localization  and expression  efficiency of calcineurin  sub- 
units  in  BHK  cells. BHK  cells  were  co-transfected with  the 
epitope-tagged CnA cDNA and either a control vector or one ex- 
pressing  CnB. The subcellular  localization  and transfection  effi- 
ciency  of CnA  were  determined by using  an  anti-HA-epitope 
polyclonal  antibody and is shown in the left micrograph.  Nuclei 
were stained  with Hoechst dye 33258 and are shown in the right 
panel. Cells expressing CnA alone are shown in the upper panel, 
and those co-expressing  CnA and CnB  are shown in the lower 
panel. 
ting with anti-HA antibodies revealed considerably higher 
levels of CnA in cells co-expressing CnA and CnB, com- 
pared to those expressing CnA alone (Fig. 1 B). It is likely 
that the assembly of CnB onto its binding site on CnA acts 
to protect  CnA  from proteolytic degradation  in  the  cell 
(Milan  et  al.,  1994).  Indirect  immunofluorescence  using 
the  anti-HA  monoclonal  antibody  detected  HA-tagged 
CnA in the cytoplasm of transfected cells, and showed that 
co-expressing CnB along with CnA yields more cells with 
detectable levels of CnA (Fig. 1 C). The indirect immuno- 
fluorescence also revealed that the vast majority of BHK 
cells grown in  normal media appears to tolerate the  co- 
expression  of  HA-CnA  and  -CnB.  However,  approxi- 
mately 3%  of transfected cells displayed hypercondensed 
nuclei and cytoskeletal changes reminiscent of cells under- 
going apoptosis (Kerr et al., 1994). Since calcineurin activ- 
ity is highly dependent on a  transient rise in intracellular 
calcium (Klee et al., 1988), we asked whether stimulating 
calcineurin  activity  by  exposing  cells  to  calcium  iono- 
phores would provoke increased rates of apoptosis in cal- 
cineurin-transfected  cells.  Cells  co-expressing  HA-CnA 
and  -CnB  for  16  h  were  treated  with  the  calcium iono- 
phore ionomycin, and scored for the apoptotic phenotype. 
Despite a  4-h incubation with ionomycin (0.25  }xM), cal- 
cineurin-transfected  cells showed only a  modest increase 
in the rate of apoptosis (Fig. 2 A). We then considered the 
possibility that, as with c-myc over-expression (Evan et al., 
1992),  growth  factor  pathways  inhibit  apoptosis  in  cal- 
cineurin-transfected  cells.  We  therefore  stimulated  cal- 
cineurin-transfected  cells with calcium ionophores after 
4 h of serum deprivation. Significantly, more than 60% of 
the  transfected cells entered  apoptosis within 4  h  (Fig. 2 
A). The process of apoptosis in these cells was very rapid: 
cytoplasmic retraction was apparent within 15 min of cal- 
cium ionophore treatment, and nuclear condensation was 
obvious at 30 min (Fig. 2 B).  By 4  h, cells were rounded 
and  had  nuclei  with  multiple  bodies  of hypercondensed 
chromatin. 
To further characterize the  apparent  apoptotic events, 
calcineurin-transfected  cells  were  treated  with  calcium 
ionophores with and without serum deprivation,  and ge- 
nomic  DNA  subsequently  probed  for  the  presence  of 
strand breaks using the  terminal deoxynucleotidyl trans- 
ferase (TdT)-mediated UTP nick end-labeling (TUNEL) 
method (Fig. 3; Tilly and Hsueh, 1993).  Calcium-activated 
cells grown in high serum showed no incorporation of la- 
beled nucleotides (Fig. 3). In contrast, apoptotic nuclei of 
calcium activated, serum-deprived cells showed strong in- 
corporation  of labeled nucleotides  indicative  of multiple 
nicks in nuclear DNA (Fig. 3). These results demonstrate 
that  transfected  calcineurin  induces  apoptosis  in  a  cal- 
cium-dependent manner and that this process of cell death 
is blocked by growth factors. 
We also note that non-transfected BHK cells, or those 
transfected  with  the  regulatory  subunit  CnB  alone,  un- 
dergo apoptosis when serum deprived for 4 h  and subse- 
quently treated with ionomycin. However, the percentage 
of apoptotic cells is only 7.5% compared to 65% in CnA/ 
CnB-transfected cells (not shown). 
Calcineurin Acts on Existing Substrates 
to Promote Apoptosis 
To  determine  whether  calcineurin-induced  apoptosis  in 
BHK cells requires new protein synthesis, we treated cells 
co-expressing CnA and CnB with the protein synthesis in- 
hibitor cycloheximide (36 }xM) immediately prior to serum 
deprivation. 1 h  after calcium ionophore treatment in the 
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Figure 2.  Induction of apopto- 
sis  in  BHK  cells  transfected 
with CnA and CnB.(A) Effect 
of serum deprivation and iono- 
mycin on induction of apopto- 
sis  in  CnA-  and  CnB-trans- 
fected  ceils.  BHK  cells  were 
transfected  with  CnA  (1  I~g) 
and  CnB  (1  t~g) cDNAs  and 
cultured  overnight  in  normal 
media  containing  10%  FCS. 
The next day, cells were serum 
deprived by incubation in low 
serum medium (0.1% FCS) for 
4 h, and then incubated in low 
serum medium with ionomycin 
(0.25  ~M,  open circles)  or 
without ionomycin (closed cir- 
cles).  Identical  coverslips  of 
transfected  cells  were  incu- 
bated in media containing 10% 
FCS  containing  ionomycin 
(closed rectangles) or without 
ionomycin  (open rectangles). 
Transfected  cells  were  scored 
for  the  apoptotic  phenotype 
including changes in cell shape 
and  hypercondensed  chroma- 
tin as judged by Hoechst 33258 
staining.  A  minimum of 1,000 
transfected cells was scored for 
each time point. (B) Apoptotic 
events  in  cells  coexpressing 
CnA/CnB.  BHK  cells  trans- 
fected  with  CnA  and  CnB 
were  serum-deprived  for 4  h, 
and  then  exposed to ionomy- 
cin (0.25 IxM) in the same me- 
dia. The morphological changes 
of cell  shape  and nuclei were 
observed  by  using  both  the 
anti-HA  epitope  antibody  to 
detect  CnA/CnB-transfected 
cells and Hoechst 33258 dye at 
the  indicated  time: 0  rain,  15 
min, 30 min, and 4 h of iono- 
mycin treatment. 
presence  or absence  of cycloheximide, cells  were  scored 
for changes in cytoplasmic and nuclear  structure  charac- 
teristic  of apoptosis.  Cycloheximide showed no effect on 
the progression of serum-deprived, calcineurin-transfected 
cells toward apoptosis upon calcium ionophore treatment, 
an indication that calcineurin stimulates cell death by act- 
ing on existing substrates in the cell (Fig. 4 A, lane 3). Di- 
rect measurement of the inhibition of protein synthesis by 
36 ixM cycloheximide revealed an 83%  decrease in the in- 
corporation  of  [35S]methionine  into  polypeptides  (not 
shown).  Significantly, cycloheximide treatment  in the ab- 
sence  of ionomycin did  not promote  cell death  in either 
the serum deprived cells or those grown in 10% FCS (Fig. 
4 A, lanes 1 and 4). In contrast, cycloheximide appears to 
neutralize  the  ability of high serum  to block calcineurin- 
induced cell death (Fig. 4 A, lane 6). In this case it is likely 
that  cycloheximide is  preventing  the synthesis  of factors 
required by the cell for survival. 
Calcineurin-induced Apoptosis Is Suppressed 
by Bcl-2 Expression 
The oncoprotein Bcl-2, and its homolog in C. elegans en- 
coded by ced9, appear to play a  major role in suppressing 
cell death provoked by a wide variety of stimuli (Sentman 
et al., 1991; Barr and Tomei, 1994; Reed, 1994). To deter- 
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CnA/CnB-transfected  cells. 
BHK cells co-expressing  CnA 
and  CnB  cDNAs  for  16  h 
were incubated in either 10% 
FCS (top) or 0.1% FCS (bot- 
tom)  for  4  h,  incubated  in 
ionomycin  (0.251xM)  in  ei- 
ther 10%  FCS or low serum 
for  1  h,  and  subsequently 
processed for immunodetec- 
tion of CnA and fragmented 
DNA  using  the  TUNEL 
method.  Left  panels  reveal 
staining  for  CnA  (red) and 
DNA (blue) in cells exposed 
to ionomycin in high and low 
serum,  respectively.  Right 
panels  show  fields  corre- 
sponding  to  left  panels  in 
which  DNA  was  labeled  at 
internal  breaks using digoxi- 
genin-modified  nucleotides 
and  terminal  deoxynucle- 
otide  transferase,  followed 
by FITC-labeled anti-digoxi- 
genin antibodies (green). 
Figure 4.  Effect of cycloheximide and Bcl-2  on BHK cells  co- 
transfected with CnA and CnB. (A) Effect of the protein synthe- 
sis  inhibitor  cycloheximide on calcineurin-induced apoptosis in 
BHK cells. Cells were co-transfected with cDNAs encoding CnA 
and CnB, and subsequently incubated for 4 h  in either normal 
media or low-serum media in the presence (lanes 1, 3, 4, and 6) or 
absence (lanes 2 and 5) of cycloheximide (36 ixM) prior to stimu- 
lation with ionomycin (0.25 IxM) for 1 h.  I and CHX represent 
ionomycin and cycloheximide, respectively.  Error bars indicate 
standard deviation of three experiments in which 800 transfected 
cells in each experiment were scored. (B) Bcl-2 expression pre- 
vents apoptosis in calcineurin-transfected cells.  BHK cells were 
transfected with cDNAs encoding CnA and CnB, CnA, CnB, and 
Bcl-2,  or Bcl-2  alone and subsequently serum-deprived for 4 h 
and stimulated with ionomycin for 1 h. The percentage of apop- 
totic cells was determined by scoring 800 cells from four experi- 
ments. Error bars represent the standard deviation for these de- 
terminations. Each column represents as follows: Vector (2.0 txg 
of pCMV control vector); Bcl-2 (0.6 Ixg of pCMV control vector 
+  1.4 Ixg of pCMV-bcl-2); A  +  B  (0.3  ~g each of pCMV-CnA 
and -CnB +  1.4 ~g of pCMV control vector); A  + B + Bcl-2 (0.3 
Ixg each of pCMV-CnA and -CnB +  1.4 ~g of pCMV-bcl-2). 
mine whether Bcl-2 can regulate calcineurin-induced apo- 
ptosis, we assayed the interaction of Bcl-2 and calcineurin 
in BHK fibroblasts. Cells expressing CnA, CnB, and Bcl-2 
were found to be markedly resistant to apoptosis induced 
by growth factor withdrawal  and ionomycin treatment  in 
comparison to cells not transfected with the Bcl-2 expres- 
sion vector (Fig. 4 B). These data suggest that the actions 
of Bcl-2  are  dominant  over  those  of calcineurin  in  cell 
death, although they fail to address whether Bcl-2 is acting 
upstream  or downstream  of calcineurin.  Regardless,  cal- 
cineurin appears to function in a pathway of cell death reg- 
ulated by Bcl-2. 
Calcium-independent Calcineurin Mutant Promotes 
Apoptosis in the Absence of Calcium Signaling 
Although calcineurin-transfected  cells undergo rapid  and 
efficient  apoptosis upon exposure  to calcium ionophores, 
it was formally possible that the calcium influx was activat- 
ing endogenous enzymes which in turn trigger cell death. 
To circumvent the requirement  for calcium ionophores in 
this  process,  we transfected  cells  with  a  COOH-terminal 
deletion mutant (ACnA) of calcineurin which is constitu- 
tively active even in the absence of elevated calcium (Fig. 
5  A;  Hubbard  and  Klee,  1989;  Clipstone  and  Crabtree, 
1992; O'Keefe et al.,  1992).  As with cells expressing  full- 
length CnA and CnB, cells expressing ACnA and CnB ap- 
pear normal 16 h after transfection (Fig. 5 B, upper panel). 
In  contrast  to  cells  expressing  the  full-length  CnA  and 
CnB, those transfected with ACnA and CnB initiated apop- 
tosis  without  exposure  to  calcium  ionophores  (Fig.  5  B, 
lower panel).  Further,  these  cells  reacted  positively  for 
fragmented  DNA  using  the  TUNEL  method  (Fig.  5  B, 
right panels). The time course for cell death after the start 
of serum deprivation  of ACnA/CnB-transfected cells was 
remarkably rapid and approached 50%  by 4  h  (Fig. 5  C). 
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Figure 5.  ACnA expression re- 
suits in apoptosis in the absence 
of  ionomycin.  (A)  Schematic 
representation  of  full-length 
(CnA) and the truncated, consti- 
tutively  active  calcineurin  A 
(ACnA).  (B)  Cells  co-trans- 
fected  with  ACnA  and  CnB 
were fixed before and after 4 h 
of  serum-deprivation  and  pro- 
cessed for  immunofluorescence 
using  the  anti-HA  monoclonal 
antibody  to  detect  ACnA  and 
Hoechst  dye  to  label  DNA 
(right) and for fragmented DNA 
using  the  TUNEL  method 
(right). (C) BHK cells were co- 
transfected with CnA and  CnB 
(open circles) or ACnA and CnB 
(closed  circles),  and  subse- 
quently transferred to low serum 
media. After 4 h of serum depri- 
vation, cells were incubated with 
ionomycin  (0.25  ixM).  At  the 
time points indicated, ceils were 
fixed,  processed  for  immuno- 
fluorescence  using the  anti-HA 
monoclonal antibody and Hoechst 
dye 33258, and analyzed for apop- 
totic  figures.  1,000 cells  from 
each of three experiments were 
scored for apoptotic nuclei. The 
vertical bars represent standard 
deviations. 
The  absolute percentage of apoptotic cells was not obvi- 
ously enhanced by the addition of ionomycin at four hours 
(Fig. 5 C). These data indicate that calcineurin can directly 
stimulate apoptotic pathways without  the cooperation of 
other calcium-activated proteins. 
Correlation between Calcineurin Catalytic Activity 
and Apoptosis 
To probe the relationship between CnA phosphatase ac- 
tivity and cell death, we  scored cells transfected with in- 
creasing  amounts  of ACnA/CnB  for  both  apoptosis  and 
calcineurin enzymatic activity. Anti-calcineurin antibodies 
were used in immunoblots to assay calcineurin accumula- 
tion in the transfected cells (Parsons et al., 1994). As seen 
in Fig. 6  A, ACnA  (50  kD)  migrates  below endogenous 
calcineurin (60 kD)  and its level of expression correlates 
with  the  amount  of ACnA plasmid used in  the  transfec- 
tion. To determine if the increased accumulation of ACnA 
is  reflected  in  enhanced  calcineurin  activity, HA-tagged 
ACnA  was  immunoprecipitated  with  the  anti-HA  anti- 
body and assayed for activity in vitro. We found a  nearly 
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Figure 6.  Correlation between calcineurin activity and apoptosis. 
(A) Dose-dependent expression of ACnA. BHK cells were trans- 
fected with the indicated amounts of ACnA/CnB expression vec- 
tors (1:1  ratio, adjusted to 2  I~g using control vector) and lysed 
16  h  later.  Cell lysates were  separated  by electrophoresis  and 
transferred  to  nylon  membrane.  Endogenous  calcineurin  A 
(CnA)  and  transfected  ACnA  were  detected  by  an  anti-cal- 
cineurin  antibody  (gift  of  R.  Kincaid,  National  Institutes  of 
Health, Bethesda, MD). (B) BHK cells transfected with different 
amounts of ACnA/CnB were assayed for calcineurin phosphatase 
activity and scored for apoptosis. To determine calcineurin activ- 
ity, cells were  lysed 16 h  after transfection and the HA-tagged 
ACnA  immunoprecipitated with  the  12CA5  monoclonal  anti- 
body. Immunoprecipitates were assayed for phosphatase activity 
against the -~2P-labeled RII peptide,  as described  (Milan et  al., 
1994).  Apoptosis was scored on identical coverslips after 4 h  of 
serum deprivation. Open circles and closed circles represent the 
percentage of apoptotic cells and phosphatase activity of the ex- 
pressed  calcineurin,  respectively.  (C)  To  compare  the  phos- 
phatase  activity of transfected  ACnA with  that  of endogenous 
calcineurin, whole  cell  lysates were  prepared  from  cells  trans- 
fected with different amounts of ACnA/CnB and control vector 
alone (total 2  txg). Calcineurin-specific phosphatase activity was 
determined in the presence of 500 nM okadaic acid to suppress 
PP1  and PP2A  (Fruman et  al.,  1992).  Lysates from cells trans- 
fected with vector alone displayed calcium-dependent and -inde- 
pendent phosphatase activity, both of which were suppressed by 
500 nM CsA and 1 IxM cyclophilin B. Lysates made from ACnA/ 
CnB-transfected  cells, assayed  in  the  absence  of calcium, dis- 
played  phosphatase  activity  proportional  to  the  amount  of 
ACnA/CnB transfected. The decrease in phosphatase activity at 1 
linear  relationship  between  the  amount  of  calcineurin 
plasmids  transfected and the phosphatase  activity of the 
immunoprecipitated calcineurin (Fig. 6 B). Moreover, these 
experiments  revealed  a  strong  correlation  between  cal- 
cineurin activity and apoptosis in transfected cells (Fig. 6 B). 
We next asked how this transfected calcineurin activity 
compared to that of endogenous calcineurin. Cells trans- 
fected with a control vector were lysed in extraction buffer 
and assayed for calcineurin activity in the presence of oka- 
daic acid (500 nM), which inhibits protein phosphatase  1 
and 2A  (Fruman et al.,  1992).  In parallel, we performed 
phosphatase assays on lysates from cells transfected with 
increasing  amounts  of ACnA/CnB,  and  found  a  corre- 
sponding increase in phosphatase activity (Fig. 6 C), as ex- 
pected from the immunoprecipitation experiments. At the 
lowest  amount  of  ACnA/CnB  transfected,  the  lysates 
yielded  a  twofold  higher  calcineurin  activity  than  that 
found  in  cells  transfected with  the  control vector alone 
(Fig. 6 C). At this level of calcineurin activity, 23% of cells 
undergo apoptosis after 4  h  of serum deprivation, versus 
3%  for control vector-transfected cells.  In  transfections 
involving 0.75 txg ACnA/CnB, lysates show approximately 
eight times the endogenous level of calcineurin catalytic 
activity, and ~40% of total cells undergo apoptosis. Over- 
all, these results indicate a strong relationship between cap 
cineurin-dependent phosphatase activity and cell death. 
Discussion 
Calcium signaling has been implicated in a wide variety of 
apoptotic stimuli and yet the critical effectors of calcium 
remain obscure. We provide evidence that the activation 
of calcineurin, a calcium/calmodulin-dependent phospha- 
tase, rapidly provokes apoptosis and is therefore a likely 
mediator of calcium signaling  leading to  cell death.  We 
show that calcineurin-induced cell death is abrogated by 
growth  factor stimulation  and  by Bcl-2 expression.  Fur- 
ther, calcineurin was shown to function at  a  posttransla- 
tional level to activate apoptosis. These data support the 
prospect that calcineurin is acting in a calcium-dependent 
manner  to  modify  existing  substrates  important  in  the 
commitment to cell death. 
Role of Calcineurin in Calcium-activated Cell Death 
Despite advances in defining proteins which regulate apo- 
ptosis,  including Bcl-2, Bax, ICE/Ced-3,  and  Ced-4, it is 
unclear how these factors are influenced by signal trans- 
duction pathways that promote cell death. Calcium signal- 
ing is associated with glucocorticoid- and activation-induced 
cell death in immature T cells, growth factor withdrawal in 
certain cell lines, and hyperactivation of N-methyl-D-aspar- 
tate receptors of neurons (Burr and Tomei, 1994; Martin 
et al., 1994; Reed, 1994). In neurons of the central nervous 
system, calcium mobilization following glutamate stimula- 
tion of N-methyl-D-aspartate receptors is strongly impli- 
cated in cell death, although the identity of the calcium- 
pxg ACnA/CnB (each 1 p~g of ACnA and CriB) is likely due to the 
induction of apoptosis observed even in the presence of 10% FCS 
(not shown). 
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1992).  The calcium-sensitivity of nitric oxide synthetase 
makes this enzyme an obvious candidate for effecting cell 
death  in  neurons  (Choi,  1992).  However, calcineurin  is 
present at very high concentrations (1-2 p,M) in the cen- 
tral  nervous system (Krinks  et  al.,  1984),  and  therefore 
may be a material factor in calcium-activated cell death in 
neurons. 
We provide several lines of evidence that calcineurin ac- 
tivity resulting from elevated intracellular calcium concen- 
tration, rather than additional calcium-activated events, is 
sufficient to induce cell death. For one, over-expression of 
the catalytic and regulatory subunits of calcineurin in fi- 
broblasts renders these cells highly vulnerable to a rapid 
form of cell death. As with c-myc over-expression, these 
cells execute cell death processes only in the absence of 
growth factor stimulation. Second, cells expressing ACnA, 
which displays calcium-independent phosphatase activity, 
undergo  apoptosis  in  the  absence  of calcium  signaling. 
Further, the extent of apoptosis in a population of cells ap- 
pears to correlate well with the phosphatase activity gen- 
erated by the expressed ACnA. That calcineurin is a direct 
activator of cell death is supported by the observation that 
calcineurin promotes cell death in the absence of de novo 
protein  synthesis.  Similarly,  neither  c-myc nor  p53  re- 
quires new protein synthesis to trigger apoptotic pathways 
(Evan et al., 1992; Caelles et al., 1994; Wagner et al., 1994). 
It is  possible, then,  that  both c-rnyc, as  a  complex with 
Max, and p53, function in cell death by repressing genes 
required for survival. Alternatively, these transcriptional 
activators may be involved in protein-protein interactions 
independent  of transcriptional  regulation  to  affect  cell 
death decisions  (Amati  et al.,  1993;  Caelles et al.,  1994; 
Wagner et al.,  1994).  Calcineurin may participate in cell 
death pathways by indirectly altering transcriptional regu- 
lation through, for instance, c-myc or p53. Alternatively, 
calcineurin  may function by  affecting regulators  of cell 
death such as Bcl-2 or Ced-3 (Yuan et al., 1993). 
Regulation of Calcineurin-induced  Cell Death 
by Bcl-2 and Growth Factors 
The ability of Bcl-2/Ced9 to prevent apoptosis due to a di- 
verse array of stimuli, including ones involving calcium sig- 
naling, suggests that it regulates a fundamental step in the 
commitment to cell death (Sentman et al., 1991; Barr and 
Tomei, 1994; Hengartner and Horvitz, 1994; Reed, 1994). 
We find that Bcl-2 efficiently suppresses apoptosis in cells 
transfected with  wild  type CnA  and  CnB,  an  indication 
that  Bcl-2  blocks  steps  affected  by  calcineurin's  phos- 
phatase activity. Bcl-2 has been implicated in the regula- 
tion of both oxygen radical formation and calcium fluxes 
from intracellular stores, and conceivably either function 
could affect calcineurin-induced cell death  (Hockenbery 
et al., 1993; Lam et al., 1994). 
Our results also demonstrate that growth factors in se- 
rum interfere with calcineurin-induced cell death.  IGF-1 
has been has been shown to block c-myc-induced apopto- 
sis  in  fibroblasts  (Evan  et  al.,  1992;  Harrington  et  al., 
1994).  Significantly, IGF-1 prevents cell death even in the 
absence of new protein synthesis, an indication that IGF-1 
operates through pathways that directly impact apoptotic 
decisions (Harrington et al., 1994).  Cell death via c-myc is 
known to depend on wild-type p53, as c-myc over-expres- 
sion in p53  n"u cell lines leads to proliferation rather than 
cell death (Hermeking and Eick, 1994). The ability of c-rnyc 
expressing p53  nutt cells to avoid cell death is thought to un- 
derlie tumor progression in  many human  cancers  (Burr 
and Tomei, 1994). We are currently testing the possibility 
that calcineurin, c-myc, and p53 interact in a common reg- 
ulatory scheme to influence decisions on cell death. 
Calcineurin Function in Apoptosis  is Fundamentally 
Different from That in T Cell Activation 
A role for calcineurin in cell death has been deduced from 
earlier studies of T cell activation. T cell hybridomas, and 
in some cases, immature T  cells, undergo cell death in a 
calcium-dependent manner thought to require calcineurin 
(Smith et al.,  1989; Fruman et al., 1992). But several fea- 
tures of cell death in T cell hybridomas suggest that it oc- 
curs via pathways distinct from those employed in the cal- 
cineurin-dependent apoptosis described here in fibroblasts. 
For one, T  cell hybridomas stimulated by anti-CD3 anti- 
bodies appear to undergo the early phases of T cell activa- 
tion  including  calcium  mobilization,  Nuclear  Factor  in 
Activated T  Cells (NFAT) activation, and cytokine tran- 
scription within 30 min, and yet cell death is not evident 
for another six to eight hours (Shi et al., 1989; Smith et al., 
1989;  Ucker et al.,  1989; Fruman et al.,  1994).  It is now 
known that much of this lag is due to the requirement of 
new protein synthesis for T  cell hybridoma death (Ucker 
et al., 1989; Crispe, 1994). In contrast, the failure of cyclo- 
heximide to impede ceil death in fibroblasts overexpress- 
ing  calcineurin  suggests  that  calcineurin  acts  to  modify 
substrates essential for apoptosis which already exist in the 
cell.  This  finding  supports  previous work  which  argued 
that important components of the cell death process are 
constitutively expressed in the cell (Raft et al., 1993). More- 
over,  the  immunosuppressants  CsA  and  FK506,  which 
block  apoptosis  in  T  cell  hybridomas,  fail  to  block  the 
more direct cell death in BHK fibroblasts described here 
(Shibasaki,  F.,  and  F.  McKeon,  manuscript  in  prepara- 
tion). This apparent dichotomy underscores the possibility 
of two distinct, calcineurin-dependent pathways leading to 
cell death.  In  T  cell  hybridomas,  CsA  blocks  the  early 
phase of T  cell activation which is necessary to promote 
the subsequent, Fas-dependent process of cell death (Singer 
and Abbas, 1994). On the other hand, the more direct, cal- 
cineurin-dependent pathways described here may involve 
substrates  favored by  calcineurin-CsA-cyclophilin com- 
plexes (Liu et al., 1991). 
In summary, we have shown that calcineurin can medi- 
ate calcium-activated cell death in mammalian cells in a 
manner regulated by the  Bcl-2 oncoprotein and  growth 
factors. The calcineurin expression system described here 
provides  an  important  model  for the  analysis  of signal 
transduction pathways that directly influence the decision 
towards cell death or growth. Finally, these results suggest 
that calcineurin may act in the calcium-activated cell death 
of neurons and cells of the immune system. 
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